โ† All deals

ANI PHARMACEUTICALS INC

Public Equity (NASDAQ)Pharmaceutical ManufacturingPublic CompanyB2B
๐Ÿ“ Princeton, New Jersey, United Statesโ€ข Founded 1999โ€ข 501-1000 employees
StreetZero Signal 57
Be the first to signal interest

About ANI PHARMACEUTICALS INC

ANI Pharmaceuticals, Inc. is a public pharmaceutical manufacturing company headquartered in Princeton, New Jersey, United States. It operates a B2B business model and has been listed on NASDAQ under ticker ANIP since its 2013 IPO. The company focuses on in-licensing, acquiring businesses, technologies, products or assets while funding commercialization efforts including sales, marketing and general corporate purposes.

LATEST FUNDINGRule 144
$386K
Announced 2026-11-16
TOTAL RAISED$582M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ANI PHARMACEUTICALS INC.

Free plan includes 3 full deal profiles every month.

Investors

Key highlights

  • Completed $306.8M Post-IPO Debt round in August 2024
  • IPO on NASDAQ in June 2013 under ticker ANIP
  • Revenue range reported as $500M-$1B
  • Headcount approximately 600
  • Underwritten public offering of common stock announced in May 2023

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account